DSG group is leading a global AI mission with hospitals to improve predictions & identify measures in order to prioritize treatments. The objectives are to * Predict deterioration risk in diagnosed COVID-19 patients * Track climate effect on symptoms development * Provide diagnostic markers based on imaging & lab measures

Clinical partners:

ARC-Sheba Hospital, Israel (among the 10th largest hospital in the west)

John Hopkins hospital (to be confirmed).

The objective is developing models for:

* Predicting deterioration risk in diagnosed COV-ID19 patients

* Studying climate effect on symptoms development

* Providing diagnostic markers based on imaging & lab measures

Your hospital data can improve early detection of deterioration, healthcare system efficiency, and save lives.

Hospitals' Deliverables & Benefits :

DSG Federated learning enables data anonymity, but each hospital gains insights surfaced from the collective larger data base:

1. Measures and accurate diagnostic markers- to enable flagging high risk patients and to  prioritize treatment.
2. Accelerated Automation of imaging results analysis, faster than radiologists.
3. Extract insights that 'average' radiologist/doctor can't extract.
4. Credit will be given to all participating hospitals In all scientific publications

The data required:   Anonymized EMR data  and\or Imaging data.

Additional optional data:

- Clinical medical notes

- Genomic data

- Any other available clinical data

DSG - GLOBAL AI CENTER OF EXCELLENCE
Founded five years ago, DSG is a team of 30 data science researchers and entrepreneurs with expertise across all Deep Learning and Machine
Learning methods and a unique method of analyzing errors in the DSG/AI model (95% success rate according to predefined goals across all industries). Experts in analyzing electronical medical records, spectrometric analysis of blood plasma, imaging, and signal processing.

Contact: Dr. Gal Noyman-Veksler, gal@datascience.co.il; +972-54-455-4647; www.datascience.co.il